Elisa Ruffo

829 total citations
10 papers, 428 citations indexed

About

Elisa Ruffo is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Elisa Ruffo has authored 10 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Immunology and 3 papers in Biomedical Engineering. Recurrent topics in Elisa Ruffo's work include CAR-T cell therapy research (5 papers), Nanowire Synthesis and Applications (3 papers) and Nanofabrication and Lithography Techniques (2 papers). Elisa Ruffo is often cited by papers focused on CAR-T cell therapy research (5 papers), Nanowire Synthesis and Applications (3 papers) and Nanofabrication and Lithography Techniques (2 papers). Elisa Ruffo collaborates with scholars based in United States, Italy and United Kingdom. Elisa Ruffo's co-authors include Tullia C. Bruno, Richard C. Wu, Dario A.A. Vignali, Creg J. Workman, Jason Lohmueller, Alexander Deiters, Andrea Graziani, Gianluca Baldanzi, Olivera J. Finn and Andrew L. Snow and has published in prestigious journals such as Nature Communications, The Journal of Immunology and PLoS ONE.

In The Last Decade

Elisa Ruffo

10 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisa Ruffo United States	7	250	203	131	61	34	10	428
Alexandro Landshammer Germany	6	322 1.3×	229 1.1×	122 0.9×	81 1.3×	22 0.6×	8	476
Hassan Sadozai Canada	10	230 0.9×	233 1.1×	101 0.8×	61 1.0×	21 0.6×	15	422
Lauryn R. Werner United States	9	263 1.1×	161 0.8×	176 1.3×	80 1.3×	37 1.1×	19	475
Bogang Wu United States	10	190 0.8×	98 0.5×	126 1.0×	37 0.6×	26 0.8×	22	379
Karine Flem‐Karlsen Norway	11	301 1.2×	263 1.3×	205 1.6×	67 1.1×	37 1.1×	15	552
Roman Hennel Germany	12	169 0.7×	145 0.7×	171 1.3×	70 1.1×	65 1.9×	13	433
Aditya Mohan United States	11	212 0.8×	201 1.0×	137 1.0×	43 0.7×	28 0.8×	26	414
Gabriel Abril-Rodríguez United States	7	242 1.0×	178 0.9×	130 1.0×	71 1.2×	25 0.7×	9	373
Mohammad Awaji Saudi Arabia	7	292 1.2×	238 1.2×	128 1.0×	45 0.7×	45 1.3×	19	487

Countries citing papers authored by Elisa Ruffo

Since Specialization

Citations

This map shows the geographic impact of Elisa Ruffo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Ruffo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Ruffo more than expected).

Fields of papers citing papers by Elisa Ruffo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Ruffo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Ruffo. The network helps show where Elisa Ruffo may publish in the future.

Co-authorship network of co-authors of Elisa Ruffo

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Ruffo. A scholar is included among the top collaborators of Elisa Ruffo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Ruffo. Elisa Ruffo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Cho, Youngbin, et al.. (2024). CAR T cell infiltration and cytotoxic killing within the core of 3D breast cancer spheroids under the control of antigen sensing in microwell arrays. APL Bioengineering. 8(3). 36105–36105. 6 indexed citations

Ruffo, Elisa, et al.. (2024). 313 Antibody-drug conjugates (ADCs) as adaptors for universal CAR T cells. Regular and Young Investigator Award Abstracts. A362–A362. 1 indexed citations

Ruffo, Elisa, et al.. (2023). Post-translational covalent assembly of CAR and synNotch receptors for programmable antigen targeting. Nature Communications. 14(1). 2463–2463. 45 indexed citations

Centonze, Sara, Luisa Racca, Elisa Ruffo, et al.. (2023). Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction. Frontiers in Immunology. 14. 1043603–1043603. 3 indexed citations

Ruffo, Elisa, et al.. (2023). Conditional Control of Universal CAR T Cells by Cleavable OFF-Switch Adaptors. ACS Synthetic Biology. 12(10). 2996–3007. 16 indexed citations

Ruffo, Elisa, et al.. (2021). Preclinical development of universal SNAP-CAR T cell therapy. The Journal of Immunology. 206(1_Supplement). 67.11–67.11. 1 indexed citations

Ruffo, Elisa, Richard C. Wu, Tullia C. Bruno, Creg J. Workman, & Dario A.A. Vignali. (2019). Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor. Seminars in Immunology. 42. 101305–101305. 262 indexed citations

Ruffo, Elisa, Alberto Massarotti, Maria Talmon, et al.. (2018). Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening. European Journal of Medicinal Chemistry. 164. 378–390. 23 indexed citations

Ruffo, Elisa, Sasha E. Larsen, Rupali Das, et al.. (2016). Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1. Science Translational Medicine. 8(321). 321ra7–321ra7. 41 indexed citations

10.

Rainero, Elena, Paolo E. Porporato, Federica Chianale, et al.. (2014). The Diacylglycerol Kinase α/Atypical PKC/β1 Integrin Pathway in SDF-1α Mammary Carcinoma Invasiveness. PLoS ONE. 9(6). e97144–e97144. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact